High Frequency Chest Wall Oscillation Devices Sales

High Frequency Chest Wall Oscillation Devices Sales Market Outlook

The global high frequency chest wall oscillation devices market is expected to reach approximately USD 2.5 billion by 2035, growing at a compound annual growth rate (CAGR) of around 9.5% during the forecast period from 2025 to 2035. Factors contributing to this robust growth include the increasing prevalence of chronic respiratory diseases, heightened awareness regarding the benefits of pulmonary therapies, and a growing aging population that requires effective respiratory care solutions. In addition, the rise in healthcare expenditure across various countries, along with technological advancements in medical devices, is further propelling market expansion. Notably, the post-COVID-19 pandemic environment has emphasized the importance of respiratory health, thereby driving demand for high-frequency chest wall oscillation devices to aid in airway clearance and improve lung function.

Growth Factor of the Market

The growth of the high frequency chest wall oscillation devices market is primarily fueled by a myriad of factors. First, the increasing incidence of respiratory conditions such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders necessitates advanced therapeutic options for effective management and treatment. Furthermore, ongoing research and development in the field of medical devices have led to innovations that enhance the efficacy and usability of these devices, making them more appealing to both healthcare professionals and patients. The rising trend toward home healthcare is another significant growth driver, as patients and caregivers seek portable and user-friendly solutions for long-term respiratory care in non-hospital settings. Additionally, government initiatives promoting awareness and accessibility to respiratory therapies have positively impacted market growth. Lastly, a growing inclination toward personalized medicine is steering the development of tailored oscillation devices that cater to individual patient needs, thus bolstering market expansion.

Key Highlights of the Market

• The market is projected to witness a CAGR of 9.5% from 2025 to 2035.
• North America holds the largest share of the market, followed closely by Europe and Asia Pacific.
• Vest therapy systems are expected to dominate the product type segment due to their widespread use in clinical practice.
• Homecare settings are anticipated to be the fastest-growing application segment, driven by the increasing preference for at-home healthcare solutions.
• Online retail channels are gaining traction as consumers turn to e-commerce platforms for convenience and better pricing.

By Product Type

Vest Therapy Systems:

Vest therapy systems are among the most extensively utilized high frequency chest wall oscillation devices, primarily due to their effectiveness in promoting airway clearance. These systems employ a specialized vest that delivers high-frequency oscillations to the chest wall, aiding in the mobilization of secretions. The ease of use and the ability to provide therapy in a comfortable, non-invasive manner make these devices appealing to both patients and healthcare providers. Moreover, advancements in technology, including Bluetooth-enabled features for monitoring and data tracking, are enhancing the user experience and promoting adherence to therapy. As a result, this product type is poised to maintain its leadership position in the market.

Intrapulmonary Percussive Ventilator:

The intrapulmonary percussive ventilator (IPV) represents another crucial segment of the high frequency chest wall oscillation devices market. IPV devices utilize rapid bursts of air pressure to create oscillations within the lungs, facilitating effective airway clearance and improving ventilation. This type of device is particularly beneficial for patients with conditions such as cystic fibrosis or other obstructive lung diseases, as it helps reduce mucus build-up and enhances respiratory function. The portability and versatility of IPV devices further contribute to their growing adoption, particularly in homecare settings, where patients require effective respiratory therapy that can be administered in a comfortable environment.

Flutter Devices:

Flutter devices are designed to provide a simple yet effective mechanism for airway clearance through high-frequency oscillation. These handheld devices work by creating vibrations in the airways, which aid in loosening and mobilizing mucus for easier expulsion. The compact size and low-cost nature of flutter devices make them accessible options for patients, especially in resource-limited settings. Furthermore, the ease of use and minimal maintenance required for these devices contribute to their popularity among patients and caregivers alike. As awareness of respiratory therapies continues to grow, the flutter device segment is expected to witness significant traction in the coming years.

Acapella Devices:

Acapella devices serve as valuable tools for respiratory therapy, combining features of both vibratory and flow resistance. These devices provide oscillation during expiration, which helps in loosening mucus and facilitating its clearance from the airways. The user-friendly design allows patients to engage in therapy without requiring assistance, making it an attractive option for homecare settings. The versatility of acapella devices makes them suitable for a variety of patient populations, including those with chronic respiratory diseases and post-operative patients. As healthcare systems increasingly prioritize patient-centered care, acapella devices are likely to see rising demand across various healthcare settings.

Cornet Devices:

Cornet devices, similar to flutter and acapella devices, utilize oscillatory pressure to aid in mucus clearance from the lungs. These devices are designed to be portable and easy to use, making them favorable for patients who require respiratory therapy in homecare settings. The cornets provide a non-invasive solution that can enhance the quality of life for patients suffering from respiratory conditions. As the aging population grows and chronic respiratory diseases become more prevalent, the market for cornets is set to expand, offering patients effective methods for managing their respiratory health.

By Application

Hospitals:

Hospitals represent one of the primary application areas for high frequency chest wall oscillation devices due to the critical need for effective respiratory therapy in acute care settings. In hospitals, these devices are frequently utilized for patients with severe respiratory distress or those recovering from surgeries that compromise respiratory function. The availability of trained healthcare professionals to operate these devices and monitor patient progress enhances their effectiveness and ensures optimal outcomes. As hospitals continue to invest in advanced respiratory care technologies, the demand for high frequency chest wall oscillation devices is likely to grow, driven by the need for improved patient care and recovery rates.

Clinics:

Clinics play a significant role in the application of high frequency chest wall oscillation devices, particularly for outpatient care. These devices are often used to assist patients with chronic respiratory conditions who require ongoing management and support. In clinical settings, the ability to provide immediate access to therapy allows healthcare providers to implement tailored treatment plans that address individual patient needs. Furthermore, clinics often serve as educational platforms for patients and caregivers, facilitating an understanding of the importance of respiratory therapy and promoting adherence to treatment regimens. Since clinics are increasingly adopting advanced therapeutic technologies, the market for oscillation devices in this segment is expected to experience steady growth.

Homecare Settings:

Homecare settings represent one of the fastest-growing application segments for high frequency chest wall oscillation devices as patients increasingly prefer to manage their respiratory conditions in the comfort of their homes. The rise in telehealth services and advancements in device portability have made it easier for patients to receive effective respiratory therapy without frequent hospital visits. Furthermore, the convenience and flexibility offered by homecare solutions enable patients to maintain a higher quality of life while managing their conditions. As the demand for home healthcare solutions continues to rise, the market for high frequency chest wall oscillation devices in homecare settings is poised for substantial growth over the next decade.

Others:

The "Others" category encompasses various applications for high frequency chest wall oscillation devices, including rehabilitation centers and nursing homes. These settings often cater to patients with diverse health requirements, necessitating flexible and adaptable respiratory therapy options. In rehabilitation centers, oscillation devices can aid in the recovery of patients with respiratory conditions following surgery or injury, while nursing homes may use these devices to support the respiratory health of elderly residents. As healthcare facilities continue to recognize the importance of comprehensive respiratory care, the demand for high frequency chest wall oscillation devices in these alternative settings is expected to increase.

By Distribution Channel

Direct Sales:

Direct sales are a key distribution channel for high frequency chest wall oscillation devices, as manufacturers often prefer to establish direct relationships with healthcare providers and institutions. This approach allows for better control over product pricing, marketing strategies, and customer service. Through direct sales, manufacturers can ensure that their devices are utilized correctly and effectively, resulting in improved patient outcomes. Additionally, direct sales facilitate ongoing communication between manufacturers and healthcare providers, enabling them to gather valuable feedback that can inform product development and enhancements. As a result, this distribution channel is likely to remain a significant contributor to market growth.

Distributor Sales:

Distributor sales play a crucial role in the high frequency chest wall oscillation devices market by expanding the reach of manufacturers to various healthcare facilities and providers. Distributors often have established networks and relationships within the healthcare sector, allowing them to effectively promote and distribute these devices. This channel is particularly beneficial for manufacturers aiming to penetrate new markets or regions without the need for extensive investment in local infrastructure. Furthermore, distributors can offer value-added services, such as training and support for healthcare professionals, which can enhance the overall adoption and effectiveness of oscillation devices. As such, distributor sales will continue to be an essential component of the market landscape.

Online Retail:

Online retail has emerged as a prominent distribution channel for high frequency chest wall oscillation devices, primarily driven by the increasing trend toward e-commerce and online healthcare solutions. Patients and caregivers are increasingly turning to digital platforms to purchase medical devices due to the convenience and accessibility offered by online shopping. Additionally, online retail allows for price comparisons and customer reviews, empowering consumers to make informed purchasing decisions. As manufacturers enhance their online presence and optimize their e-commerce platforms, the online retail channel is expected to grow significantly, providing an efficient means of reaching a wider audience and facilitating better access to respiratory therapies.

Others:

The "Others" category includes alternative distribution channels, such as medical supply stores and specialty healthcare providers. These channels serve as complementary options for patients seeking high frequency chest wall oscillation devices, providing additional accessibility and convenience. Medical supply stores often cater to local communities, ensuring that patients have access to necessary medical devices without needing to navigate complex online platforms. Specialty healthcare providers, on the other hand, may offer tailored solutions and personalized support for patients with specific respiratory conditions. As these alternative distribution channels continue to evolve and expand, they will contribute to the overall market growth for high frequency chest wall oscillation devices.

By User

Adults:

Adults comprise a significant user segment for high frequency chest wall oscillation devices, particularly those suffering from chronic respiratory diseases such as COPD and asthma. These conditions often require ongoing management and therapeutic interventions, making oscillation devices a critical component of adult respiratory care. The increasing prevalence of adult respiratory ailments, coupled with a growing emphasis on proactive health management, is driving the demand for effective airway clearance therapies. Additionally, adults are more likely to engage in home healthcare solutions and utilize portable oscillation devices, further amplifying demand in this segment.

Pediatrics:

Pediatrics represent another important user segment for high frequency chest wall oscillation devices, particularly for children diagnosed with conditions like cystic fibrosis and other respiratory disorders. Pediatric patients often require specialized respiratory therapies that cater to their unique physiological needs, making oscillation devices a valuable tool for healthcare providers. The ability to administer these therapies in a non-invasive and comfortable manner enhances patient compliance and promotes improved health outcomes. As awareness of pediatric respiratory health continues to grow, the demand for high frequency chest wall oscillation devices tailored for this age group is expected to increase significantly.

Geriatrics:

The geriatric population is a critical user segment for high frequency chest wall oscillation devices, as elderly individuals often experience a higher prevalence of chronic respiratory conditions. The unique challenges faced by this demographic include decreased lung function, increased susceptibility to respiratory infections, and difficulties in managing complex health issues. As a result, effective respiratory therapies are essential for improving the quality of life for geriatric patients. High frequency chest wall oscillation devices provide a non-invasive and user-friendly solution that enables elderly patients to manage their respiratory health in various settings, including homecare environments and assisted living facilities.

By Region

The North American region dominates the high frequency chest wall oscillation devices market, accounting for a substantial share of the overall market revenue. Factors contributing to this dominance include a well-established healthcare infrastructure, high healthcare expenditure, and a growing prevalence of respiratory conditions among the population. The increasing adoption of advanced medical technologies and a focus on enhancing respiratory care contribute to the market growth in this region. Additionally, the United States, as the largest market within North America, is expected to witness a CAGR of around 9.8% during the forecast period, driven by innovations in respiratory therapies and rising awareness of chronic respiratory diseases.

Europe ranks as the second-largest market for high frequency chest wall oscillation devices, thanks to a robust healthcare system and increasing emphasis on respiratory health. The European market is characterized by a growing aging population, which is more susceptible to chronic respiratory conditions requiring effective management solutions. Furthermore, government initiatives aimed at improving respiratory care and promoting access to innovative medical technologies are expected to enhance market growth in this region. The Asia Pacific region is also anticipated to witness significant growth, driven by rising healthcare expenditures, increasing awareness of respiratory therapies, and a growing middle-class population seeking advanced healthcare solutions.

Opportunities

The high frequency chest wall oscillation devices market presents numerous opportunities for growth in the coming years, particularly in the area of product innovation and development. As manufacturers increasingly focus on research and development efforts, there is potential for the introduction of advanced therapeutic devices that offer enhanced features such as remote monitoring capabilities, integration with telehealth platforms, and user-friendly designs tailored for specific patient needs. These innovations not only improve patient outcomes but also align with the trend toward personalized medicine, where treatments can better address the unique requirements of individual patients. Additionally, as healthcare providers continue to prioritize patient-centered care, the demand for effective and accessible respiratory therapy solutions will only continue to rise, creating a favorable environment for market expansion.

Moreover, the growing trend towards home healthcare presents a significant opportunity for high frequency chest wall oscillation devices. As patients increasingly prefer to manage their health conditions from the comfort of their homes, the demand for portable and easy-to-use respiratory devices is expected to grow. This shift towards homecare solutions is further supported by the rise of telehealth services, enabling patients to receive real-time guidance and support from healthcare professionals. Manufacturers that can effectively cater to the homecare market with innovative, high-quality oscillation devices will likely gain a competitive advantage and experience substantial growth in the coming years.

Threats

The high frequency chest wall oscillation devices market faces several threats that could hinder its growth trajectory. One significant challenge is the increasing competition from alternative therapies, including pharmacological treatments and other non-invasive airway clearance methods. As new therapies emerge and are validated through clinical studies, patients and healthcare providers may opt for these alternatives over oscillation devices, potentially impacting market share. Additionally, the high cost of advanced oscillation devices may deter some patients from utilizing these therapies, particularly in regions with limited healthcare funding or resources. This financial barrier could result in decreased adoption rates, which in turn could stifle market growth.

Another potential restraining factor for market growth is the regulatory landscape surrounding medical devices. Manufacturers of high frequency chest wall oscillation devices must navigate stringent regulatory requirements for product approval, which can result in lengthy delays and increased costs. Furthermore, any changes in regulatory standards or adverse events associated with these devices could lead to increased scrutiny and may affect market sentiment. As the industry evolves and new regulations emerge, manufacturers must remain vigilant and adaptable to ensure compliance while continuing to innovate and meet the needs of patients and healthcare providers.

Competitor Outlook

• Hill-Rom Holdings, Inc.
• Medtronic, Inc.
• Smiths Medical
• Airway Management, Inc.
• Respiratory Technologies, Inc.
• Vyaire Medical, Inc.
• Dynarex Corporation
• Pari Respiratory Equipment, Inc.
• Pneumatic Scientific, Inc.
• Inspira Technologies Oxy B.H.N. Ltd.
• Hollister Incorporated
• Allied Healthcare Products, Inc.
• Drive DeVilbiss Healthcare
• Philips Respironics
• SeQual Technologies, Inc.

Overall, the competitive landscape of the high frequency chest wall oscillation devices market is characterized by a diverse range of players that are actively engaged in product innovation, strategic collaborations, and market expansion initiatives. Established companies with significant market presence, such as Medtronic and Hill-Rom Holdings, continue to dominate the market through their comprehensive portfolios of oscillation devices and related respiratory therapies. These companies benefit from their extensive networks and relationships within the healthcare sector, allowing them to effectively distribute their products and offer superior customer support and training. Furthermore, ongoing investments in research and development enable these companies to stay ahead of industry trends and adapt to changing market demands.

In contrast, emerging companies and startups are also making their mark on the high frequency chest wall oscillation devices market by introducing innovative technologies and solutions that cater to niche segments. These companies often focus on enhancing user experience, improving device performance, and reducing costs, which can establish them as competitive challengers to larger, more established players. Additionally, collaborations and partnerships with healthcare providers and research institutions can facilitate the development of cutting-edge products that address unmet needs within the respiratory care landscape. As the market evolves, the interplay between established firms and emerging players will shape the competitive dynamics and drive further advancements in high frequency chest wall oscillation technology.

Among the major companies in the high frequency chest wall oscillation devices market, Hill-Rom Holdings, Inc. stands out as a key player known for its wide range of respiratory care solutions. The company is committed to enhancing patient outcomes through innovative technologies and has a strong focus on research and development. Hill-Rom’s products, including its vest therapy systems, are widely used in hospitals and homecare settings, contributing to its leadership position in the market. Additionally, the company's strategic acquisitions and partnerships have strengthened its product offerings and expanded its global reach.

Another significant player in the market is Medtronic, Inc., which leverages its extensive expertise in medical devices to develop high-frequency oscillation solutions that address the needs of patients with complex respiratory conditions. Medtronic's commitment to innovation is reflected in its advanced oscillation technologies, which improve therapy delivery and patient compliance. The company's strong global presence and robust distribution channels enable it to reach a diverse customer base, further solidifying its position in the high frequency chest wall oscillation devices market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Smiths Medical
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Dynarex Corporation
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Philips Respironics
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Vyaire Medical, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Hollister Incorporated
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Airway Management, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Hill-Rom Holdings, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 SeQual Technologies, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Drive DeVilbiss Healthcare
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Pneumatic Scientific, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Respiratory Technologies, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Allied Healthcare Products, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Pari Respiratory Equipment, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Inspira Technologies Oxy B.H.N. Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 High Frequency Chest Wall Oscillation Devices Sales Market, By User
    • 6.1.1 Adults
    • 6.1.2 Pediatrics
    • 6.1.3 Geriatrics
  • 6.2 High Frequency Chest Wall Oscillation Devices Sales Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Clinics
    • 6.2.3 Homecare Settings
    • 6.2.4 Others
  • 6.3 High Frequency Chest Wall Oscillation Devices Sales Market, By Product Type
    • 6.3.1 Vest Therapy Systems
    • 6.3.2 Intrapulmonary Percussive Ventilator
    • 6.3.3 Flutter Devices
    • 6.3.4 Acapella Devices
    • 6.3.5 Cornet Devices
  • 6.4 High Frequency Chest Wall Oscillation Devices Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales
    • 6.4.3 Online Retail
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 High Frequency Chest Wall Oscillation Devices Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global High Frequency Chest Wall Oscillation Devices Sales market is categorized based on

By Product Type

• Vest Therapy Systems
• Intrapulmonary Percussive Ventilator
• Flutter Devices
• Acapella Devices
• Cornet Devices

By Application

• Hospitals
• Clinics
• Homecare Settings
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales
• Online Retail
• Others

By User

• Adults
• Pediatrics
• Geriatrics

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Hill-Rom Holdings, Inc.
• Medtronic, Inc.
• Smiths Medical
• Airway Management, Inc.
• Respiratory Technologies, Inc.
• Vyaire Medical, Inc.
• Dynarex Corporation
• Pari Respiratory Equipment, Inc.
• Pneumatic Scientific, Inc.
• Inspira Technologies Oxy B.H.N. Ltd.
• Hollister Incorporated
• Allied Healthcare Products, Inc.
• Drive DeVilbiss Healthcare
• Philips Respironics
• SeQual Technologies, Inc.